Replaces Prod. #: BML-C112
M2 muscarinic receptor antagonist with pronounced cardioselectivity. Acts via allosteric modulation of preceptor binding.
Product Specification
| Formula: | C30H60N3O3I3 |
| |
| MW: | 891.5 |
| |
| Appearance: | White to off-white solid. |
| |
| CAS: | 65-29-2 |
| |
| MI: | 14: 4343 |
| |
| RTECS: | BS1100000 |
| |
| Solubility: | Soluble in water (25mg/ml) or 100% ethanol. |
| |
| Long Term Storage: | +4°C |
| |
| Hazard: | HARMFUL. |
| |
| Handling: | Hygroscopic. |
| |
Please mouse over
Product Literature References
On the interaction of gallamine with muscarinic receptor subtypes: A.D. Michel et al.; Eur. J. Pharmacol.
182, 335 (1990),
Abstract;
Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea: T. Kenakin & C. Boselli ; J. Pharmacol. Exp. Ther.
250, 944 (1989),
Abstract;
Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat: R. Hammer et al.; Life Sci.
38, 1653 (1986),
Abstract;
Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs: J. Nedoma et al.; J. Pharmacol. Exp. Ther.
236, 219 (1986),
Abstract;